火针联合刺络放血对慢性湿疹瘙痒程度影响的研究

Clinical Research of Influence of Integrated Therapy of Fire Needle and Bloodletting on Itch in Chronic Eczema

目的观察火针联合刺络放血疗法对慢性湿疹瘙痒程度的改善情况,为本疗法提供临床依据;并通过与其他疗法的比较,探讨对于缓解慢性湿疹的瘙痒症状更加有效的疗法。方法将符合标准的慢性湿疹患者随机分为4组:火针组、刺络放血组、火针联合刺络放血组以及西药对照组,观察治疗前后VAS评分数据变化,判断治疗方案对于瘙痒的疗效,并对起效时间和疗效维持时间进行比较。结果 (1)各组治疗后VAS评分均明显下降(P<0.05);治疗3个疗程后,3个治疗组VAS评分下降程度均较对照组明显(P<0.05)。(2)3个治疗组起效时间差异与对照组比较差异有统计学意义;火针联合刺络放血组与刺络放血组起效时间差异有统计学意义,火针组与刺络放血组及火针联合刺络放血组起效时间比较差异无统计学意义。(3)3个治疗组疗效维持时间与对照组比较差异均有统计学意义;3个治疗组疗效维持时间差异无统计学意义。结论火针联合刺络放血疗法能够明显改善慢性湿疹的瘙痒程度,并具备起效时间短的治疗优势。

Objective To provide clinical evidence for integrated therapy of fire needle with bloodletting, by observing the efficacy on the improvement of itch in treating chronic eczema, and to explore the best therapy for improving itch of chronic eczema by comparing with other therapies. Methods Patients meeting the criteria were randomized into four groups： fire needle group, bloodletting group, integrated therapy of fire needle with bloodletting group, and modern medicine group. Then we compared the scores of VAS before and after the treatment to assess the efficiency of different therapies on itch, and to compare the onset time and effect-maintaining time. Results（1） VAS scores were all decreased after treating（P〈0.05）; VAS scores in three treatment groups were significantly decreased compared with modern medicine group（P〈0.05） after three sessions.（2）The onset times in three treatment groups were significantly decreased compared with that of that of modern medicine group（P〈0.05） after three sessions. The onset time in integrated therapy of fire needle with bloodletting was statistically significant compared with that of bloodletting therapy, while there was no statistical significance in fire needle group and integrated group.（3）The effect maintaining time in three treatment groups were statistically significant compared with modern medicine group,while there was no statistical significance in three groups. Conclusion Integrated therapy of fire needle with bloodletting could significantly improve itch of chronic eczema, and has the advantage of less onset time.